Dechra Pharmaceuticals Posts Higher FY14 Pretax Profit

Dechra Pharmaceuticals PLC (OTC: DPHAF) reported a 72% rise in its fiscal 2014 pretax profit and lifted its dividend payment.

Dechra Pharma's posted a pretax profit of 21.4 million pounds ($35 million), versus GBP12.5 million, in the year-earlier period.

Its revenue rose to GBP193.6 million from GBP189.2 million.

Dechra Pharma announced its plans to pay a final dividend of 10.65 pence per share.